Loading in 2 Seconds...
Loading in 2 Seconds...
ANTIMICROBIAL USE AND RESISTANCE SURVEILLANCE PILOT PROJECT – LESSONS FROM THE DURBAN SITE.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Gray AL, Essack SY, Deedat F, Pillay T, van Maasdyk J, Holloway K, Sorensen TL, Sturm AWDept. Pharmacology and Dept. Medical Microbiology, Nelson R Mandela School of Medicine, School of Pharmaceutical Sciences, Univ. KwaZulu-Natal, Durban, South Africa, WHO/EDM, Geneva
Problem Statement: The World Health Organization’s global strategy for containing antimicrobial resistance recommends the development of methodologies that will enable developing countries to identify and track resistance trends in specific infections and geographical locations. Standard methods for such surveillance systems do not exist for resource-constrained settings.
Objectives: To investigate the association between antibiotic use and resistance over time in respiratory tract infections in the Inner West metropolitan area of Durban.
Design: Retrospective, time series analysis of antimicrobial use data and antimicrobial resistance of selected isolates.
Setting and population: 7 randomly selected private pharmacies, 7 convenience sampled private dispensing practitioners and 7 randomly selected state-operated nurse-managed primary health care clinics.
Methods: Antimicrobial use data were obtained from prescription records at sites representing a broad spectrum of socio-economic conditions and prescriber types. Sputum specimens were obtained from consenting patients presenting with self-reported cough with or without fever at 4 sites in the selected geographical locale. Cultures positive for Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis were subjected to MIC determinations against ampicillin, erythromycin, chloramphenicol, cotrimoxazole and ciprofloxacin by means of agar dilution. NCCLS breakpoints were applied to determine resistance.
Outcome measures: Percentage of patients seen (or prescriptions dispensed) in which an antimicrobial was prescribed; antimicrobial usage in Defined Daily Doses per 100 patients seen; percentage susceptibility of selected isolates.
Results: High usage of older antimicrobial agents was seen in public sector clinics and lower usage of a wide range of agents, including newer broad-spectrum antimicrobials, in the private sector. Percentage resistance of selected isolates by time series per quarter showed an decreasing level of resistance amongst pneumococci to ampicillin and erythromycin, but continuously total resistance to cotrimoxazole. Increasing trends in resistance to ampicillin were shown amongst H influenzae, but decreasing trends in resistance to cotrimoxazole.
Conclusions: Although no direct relationship between resistance levels and antimicrobial usage could be shown, the feasibility of establishing a system to generate data of this sort was demonstrated. Further analysis over time is planned.
Study funded by: World Health Organization.
Thanks to: WHO/EDM for funding this pilot project, the fieldworkers and laboratory staff, the staff at the facilities, for allowing us access to their patients and their data, the patients who provided sputum samples